CANCER DRUG DEVELOPMENT COMES OF AGE Trademark

Trademark Overview

On Thursday, August 20, 2020, a trademark application was filed for CANCER DRUG DEVELOPMENT COMES OF AGE with the United States Patent and Trademark Office. The USPTO has given the CANCER DRUG DEVELOPMENT COMES OF AGE trademark a serial number of 90127064. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 2, 2022. This trademark is owned by Day One Therapeutics, Inc.. The CANCER DRUG DEVELOPMENT COMES OF AGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
cancer drug development comes of age

General Information

Serial Number90127064
Word MarkCANCER DRUG DEVELOPMENT COMES OF AGE
Filing DateThursday, August 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 2, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements

Disclaimer with Predetermined Text"CANCER DRUG DEVELOPMENT"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 24, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDay One Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameDay One Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, May 2, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 2, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 28, 2021SOU EXTENSION 1 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 1 FILED
Tuesday, September 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 24, 2021CORRECTED NOA E-MAILED
Friday, April 23, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, April 22, 2021ASSIGNED TO PETITION STAFF
Tuesday, March 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Friday, January 15, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 23, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 22, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, December 22, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 22, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, December 22, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 16, 2020ASSIGNED TO EXAMINER
Thursday, September 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 24, 2020NEW APPLICATION ENTERED

Related Keywords

comes development drug cancer fields biotechnology pharmaceutical research